Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bithionol sulfoxide is a clinically approved antiparasitic drug with the inhibitory against solid tumor growth in several preclinical cancer models.
产品描述 | Bithionol sulfoxide is a clinically approved antiparasitic drug with the inhibitory against solid tumor growth in several preclinical cancer models. |
体外活性 | Bithionol caused dose-dependent cytotoxicity against all ovarian cancer cell lines tested (IC50s: 19 μM - 60 μM). BT treatment resulted in cell cycle arrest at the G1/M phase and increased ROS generation [1]. Both bithionol and bithionol sulphoxide demonstrated in vitro toxicity to Neoparamoeba spp. at all concentrations examined (0.1 to 10 mg/l over 72 h), with comparable toxicity to freshwater observed for both chemicals at concentrations > 5 mg/l following a 72 h treatment [2]. |
分子量 | 372.05 |
分子式 | C12H6Cl4O3S |
CAS No. | 844-26-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (671.95 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.6878 mL | 13.4391 mL | 26.8781 mL | 67.1953 mL |
5 mM | 0.5376 mL | 2.6878 mL | 5.3756 mL | 13.4391 mL | |
10 mM | 0.2688 mL | 1.3439 mL | 2.6878 mL | 6.7195 mL | |
20 mM | 0.1344 mL | 0.672 mL | 1.3439 mL | 3.3598 mL | |
50 mM | 0.0538 mL | 0.2688 mL | 0.5376 mL | 1.3439 mL | |
100 mM | 0.0269 mL | 0.1344 mL | 0.2688 mL | 0.672 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Bithionol sulfoxide 844-26-8 Others Inhibitor inhibitor inhibit